Alkermes Inc. plc
Market Cap
6.9B
Short interest (May 15)
11.0%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.41%
↑ 46.3%
Available Shares
1M
↓ 38.2%
Price Chart
Company Overview
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.